Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT02112916
- NCI-2014-00712, NCI-2014-00712, AALL1231, U10CA180886, U10CA098543
Trial sponsor
National Cancer Institute (NCI)
Scientific Title
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)